These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In the pursuit of industrial proteomics. Mitchell P Nat Biotechnol; 2003 Mar; 21(3):233-7. PubMed ID: 12610565 [No Abstract] [Full Text] [Related]
3. The power of genomics to transform the biotechnology industry. Haseltine WA Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259 [No Abstract] [Full Text] [Related]
4. Enabling parallel protein analysis through mass spectrometry. Domon B; Alving K; He T; Ryan TE; Patterson SD Curr Opin Mol Ther; 2002 Dec; 4(6):577-86. PubMed ID: 12596360 [TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical research: cost savings through innovation. Cohen KR; Levy RA AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463 [No Abstract] [Full Text] [Related]
6. In silico drug discovery: tools for bridging the NCE gap. Larvol BL; Wilkerson LJ Nat Biotechnol; 1998 May; 16 Suppl():33-4. PubMed ID: 9591262 [No Abstract] [Full Text] [Related]
7. [Development of an antihypertensive agent. Methodology and cost]. Duchier J; Guinot P Arch Mal Coeur Vaiss; 1979 Oct; 72(10):1151-4. PubMed ID: 120723 [TBL] [Abstract][Full Text] [Related]
8. Canada's huge pregnant-mare-urine industry faces growing pressure from animal-rights lobby. Williams LS CMAJ; 1994 Oct; 151(7):1009-12. PubMed ID: 7922911 [No Abstract] [Full Text] [Related]
9. Previsible silver staining of protein in electrophoresis gels with mass spectrometry compatibility. Jin LT; Li XK; Cong WT; Hwang SY; Choi JK Anal Biochem; 2008 Dec; 383(2):137-43. PubMed ID: 18804088 [TBL] [Abstract][Full Text] [Related]
11. [Small-scale analysis of protein phosphorylation and glycosylation using two-dimensional gel electrophoresis and mass spectrometry]. Takemori N; Komori N; Matsumoto H Tanpakushitsu Kakusan Koso; 2007 May; 52(5):456-62. PubMed ID: 17491327 [No Abstract] [Full Text] [Related]
12. Proteomics. Proteomics ponders prime time. Service RF Science; 2008 Sep; 321(5897):1758-61. PubMed ID: 18818332 [No Abstract] [Full Text] [Related]
13. Proteomics and automation. Quadroni M; James P Electrophoresis; 1999; 20(4-5):664-77. PubMed ID: 10344232 [TBL] [Abstract][Full Text] [Related]
14. Proteomics: the basic overview. Figeys D Methods Biochem Anal; 2005; 45():1-62. PubMed ID: 19235290 [No Abstract] [Full Text] [Related]
15. Shotgun proteomics: tools for the analysis of complex biological systems. Wu CC; MacCoss MJ Curr Opin Mol Ther; 2002 Jun; 4(3):242-50. PubMed ID: 12139310 [TBL] [Abstract][Full Text] [Related]
16. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in bigger plants]. Forster O Pharm Acta Helv; 1973; 48(8):455-70. PubMed ID: 4766787 [No Abstract] [Full Text] [Related]
17. [Drug development costs are overstated by the industry]. Jeppsson A Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545 [No Abstract] [Full Text] [Related]
18. Comparison of indirect and direct approaches using ion-trap and Fourier transform ion cyclotron resonance mass spectrometry for exploring viperid venom proteomes. Fox JW; Ma L; Nelson K; Sherman NE; Serrano SM Toxicon; 2006 May; 47(6):700-14. PubMed ID: 16574175 [TBL] [Abstract][Full Text] [Related]
19. Proteomics: one small step for a digital computer, one giant leap for humankind. Geisow MJ Nat Biotechnol; 1998 Feb; 16(2):206. PubMed ID: 9487532 [No Abstract] [Full Text] [Related]
20. Hospital cost controls will stifle new drug technology. Hoffmann RP Hosp Pharm; 1983 Aug; 18(8):397. PubMed ID: 10261789 [No Abstract] [Full Text] [Related] [Next] [New Search]